Navigating dual compliance: Manufacturers’ obligations under the EU AI Act and MDR for AI systems

This paper analyses manufacturers’ dual obligations under the European Union (EU) AI Act and Medical Device Regulation (MDR). It shows that divergent classification rules generate parallel high-risk pathways, that post-market surveillance regimes differ in scope and mechanics, and that human oversight duties remain undefined in audit-ready, clinical terms. Friction is most acute in continuously learning models, where the MDR’s static clinical evaluation assumptions collide with the AI Act’s demand for ongoing validation. These conflicts increase compliance costs, delay market access and favour incumbents. The paper recommends procedural harmonisation: joint guidance, integrated conformity workstreams, explicit thresholds for model updates, auditable oversight controls and interoperable monitoring systems. It concludes that coordinated supervisory practice and compliance-by-design governance are the most workable means of aligning device safety with artificial intelligence (AI)-specific risk management. This article is also included in The Business & Management Collection which can be accessed at https://hstalks.com/business/.

Authors

Institutions

Publication Details

Journal
Journal of data protection & privacy.
Published
2026-11-16
DOI
https://doi.org/10.69554/eouk1487
Primary Topic
Digitalization, Law, and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Navigating dual compliance: Manufacturers’ obligations under the EU AI Act and MDR for AI systems

Michael Borrelli, Charles Kerrigan, Sean Musch, Eva Dias COSTA
2 links
Journal of data protection & privacy.
Digitalization, Law, and Regulation
article

Navigating dual compliance: Manufacturers’ obligations under the EU AI Act and MDR for AI systems

Michael Borrelli, Charles Kerrigan, Sean Musch, Eva Dias COSTA
article en

Abstract

This paper analyses manufacturers’ dual obligations under the European Union (EU) AI Act and Medical Device Regulation (MDR). It shows that divergent classification rules generate parallel high-risk pathways, that post-market surveillance regimes differ in scope and mechanics, and that human oversight duties remain undefined in audit-ready, clinical terms. Friction is most acute in continuously learning models, where the MDR’s static clinical evaluation assumptions collide with the AI Act’s demand for ongoing validation. These conflicts increase compliance costs, delay market access and favour incumbents. The paper recommends procedural harmonisation: joint guidance, integrated conformity workstreams, explicit thresholds for model updates, auditable oversight controls and interoperable monitoring systems. It concludes that coordinated supervisory practice and compliance-by-design governance are the most workable means of aligning device safety with artificial intelligence (AI)-specific risk management. This article is also included in The Business & Management Collection which can be accessed at https://hstalks.com/business/.

Journal of data protection & privacy.Vol. 9(2)
Ridge and Partners (United Kingdom) (GB)
Good health and well-being
Digitalization, Law, and Regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon